Using 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s new Agility multi-leaf collimator (MLC) radiation therapy treatment for cancer patients recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA), enabling U.S. medical centers to use it for patients with cancer.
An MLC is device made up of numerous, individual tungsten “leaves,” which shape beams of therapeutic radiation that are delivered from different angles around the patient. Using twice the number of leaves typical of many standard MLC’s, Agility precisely delivers radiation to the unique contours of the tumor, while reducing the risk of exposure to healthy tissue.
The new Agility MLC also includes ultra-fast leaf movements, twice as fast as other MLCs commonly used in the industry, enabling clinicians to further exploit the most advanced cancer therapies such as stereotactic radiosurgery (SRS), stereotactic radiation therapy (SRT) and Volumetric Modulated Arc Therapy (VMAT). Further, with a new lower radiation leakage design, research has shown Agility can significantly reduce the patient’s non-therapeutic radiation exposure as compared to other conventional MLC’s.¹
Soon after Elekta received CE marking for Agility, permitting sales of the device in Europe, clinicians began reporting significant gains in beam-shaping ability and delivery speed. Shorter treatment times have resulted in increased patient comfort and convenience, as well as improved the ability for caregivers to treat more patients each day.
¹ Cosgrove, VP, Thompson, C, Chrisophides, D et al. (2009) Physical characterization of a new concept design of an Elekta Radiation Head with integrated 160-leaf multi-leaf collimator. Poster presented at ASTRO 2009.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Sexual Fantasies: Threesomes Are Normal, Golden Showers Not So Much
- Ghost Light From Dead Galaxies - A Hubble Halloween
- Mediterranean Diet Linked To Better Kidney Health
- US Wildlife Bans On GMOs And Neonics Lack Transparency And Scientific Rationale
- Greenpeace Says Its GMOs Are Better Than Science's GMOs, Still Hates Golden Rice
- Does Max Tegmark Kill A Daughter In A Parallel World ?
- Game Theory: When Are Groups Social? Or Insufferable?
- "well, since Soylent Green is people, that probably explains it...."
- "*Low* out-of-pocket payments for health care is precisely why health care is so expensive. Approximately..."
- "Always love reading your articles Hank :) and any knowledgeable person about science knows what..."
- "Ah - sorry, but regardless that this may be taken as disdain again by you, you seem to simply have..."
- "Twelve years in a major urban public school system, and I couldn't once bring myself to eat a school..."
- Anti-GMO bungle: Claim GM genes pass from food into blood collapses
- GLP Infographic: Is labeling GMOs really about our “Right to Know”?
- Battle of Britain: NGOs and scientists clash over proposal to loosen EU GMO restrictions
- Genetically modified clean energy from bacteria
- Designer babies: You can screen for cystic fibrosis but intelligence is a ways off
- Science as profane: What superstition of 1752 and 2014 share in common
- Report examines health care challenges for pregnant women enrolled in covered California
- NYU research: Majority of high school seniors favor more liberal marijuana policies
- ESA Frontiers November preview
- Sexual fantasies: Are you normal?
- Synthetic lethality offers a new approach to kill tumor cells, explains Moffitt researcher